Profile: ThermoGenesis Corp (KOOL.O)

ThermoGenesis Corp., incorporated on July 3, 1986, designs, develops and commercializes devices and disposable tools for the processing, storage and administration of cell and tissue therapies used in the practice of regenerative medicine. The Company's products automate the volume reduction and cryopreservation of adult stem cell concentrates from cord blood and bone marrow for use in laboratory and point of care settings. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. The Company provides products and technologies to enables cell separation, processing and cryopreservation for storage of biological fluids, including umbilical cord blood, peripheral blood and bone marrow in a format. These products and technologies are designed for use in the laboratory, as well as point of care. In Januray 2013, the Company sold its ThermoLine plasma freezer and thawer product line to Helmer Scientific.

The Company’s AXP System is a medical device with an accompanying disposable bag set that isolates and retrieves stem cells from umbilical cord blood. The AXP System provides cord blood banks with an automated method to concentrate adult stem cells which reduce the overall processing and labor costs. The AXP System retains over 97% of the mononuclear cells (MNCs). The Company's market for the AXP System includes both private and public cord blood banks. The BioArchive System is designed to store over 3,600 stem cell samples. The Res-Q 60 BMC, is a product for cell processing at the point of care. The product is a centrifuge-based disposable device designed for the isolation and extraction of specific stem cell populations from bone marrow.

The Company’s MarrowXpress or MXP System, is a product of the AXP and its accompanying disposable bag set, isolates and concentrates stem cells from bone marrow aspirate and its initial application is for the preparation of cells for regeneration of bone in spinal fusion procedures. The Res-Q 60 PRP is designed to be used for the safe and rapid preparation of autologous PRP from a small sample of blood at the point of care. The product allows PRP to be mixed with autograft and/or allograft bone prior to application to a bony defect in the body.

The Company’s CryoSeal System is an automated system serving the wound market used to prepare an autologous hemostatic surgical sealant from a patient's own blood or from a single donor in approximately one hour. On June 30, 2012, Asahi Kasei Medical Co., Ltd. (Asahi) exercised the option to purchase certain intangible assets related to this product line, including all associated patents, trademarks and engineering files. The ThermoLine product line includes the ultra-rapid plasma ThermoLine Freezer and ultra-rapid plasma ThermoLine Thawer.

The Company competes with BioSafe/Sepax, BioE, Pall Corporation, Chart Industries, Taylor-Wharton, COBE Spectra, Ficoll-Paque, Terumo Cardiovascular Systems/SmartPReP2, Biomet/MarrowStim, Biomet/GPS III and the BioCUE.